Doctor profile · Federal record

Dr. Natalia Filipof

Specialist (CMS: Internal Medicine) · Grosse Pointe Woods, MI

  • NPI 1245340975
  • Accepts Medicare
  • MIPS 85.2 / 100 · 2023
  • 32 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
20030 Mack Ave
Grosse Pointe Woods, MI 482362323
(313) 884-3380
fax (313) 884-9756
Mailing address
581 Ballantyne RD
Grosse Pointe Shores, MI 482362635

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
October 8, 2020
Year of graduation
1994 — 32 yrs since
Specialty taxonomy
174400000X — NUCC code

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1245340975. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,555
Distinct HCPCS
10
Medicare allowed
$237,559
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,723 216 $7
99213 Established patient office or other outpatient visit, 20-29 minutes 695 477 $90
17000 Destruction of precancer skin growth, 1 growth 638 303 $53
17110 Destruction of skin growth, 1-14 growths 479 269 $112
11102 Biopsy of related skin growth, first growth 224 196 $89
99212 Established patient office or other outpatient visit, 10-19 minutes 180 151 $57
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 146 58 $1
11900 Injection into skin growth, 1-7 growths 59 38 $46
11901 Injection into skin growth, more than 7 growths 55 11 $71
99214 Established patient office or other outpatient visit, 30-39 minutes 54 38 $129

In context: peer comparison

Among 1 peers in Grosse Pointe Woods Specialist, average services per provider: 216. This provider delivers 21× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,759
Transactions
133
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 14 $550.09
Novartis Pharmaceuticals Corporation 35 $453.62
Genzyme Corporation 14 $365.14
Galderma Laboratories, L.P. 11 $358.82
Janssen Biotech, INC. 11 $344.37
Abbvie INC. 12 $327.66
Sun Pharmaceutical Industries INC. 4 $277.87
Arcutis Biotherapeutics, INC. 7 $276.51
Regeneron Healthcare Solutions, INC. 6 $208.94
Regeneron Pharmaceuticals, INC. 2 $193.24
Lilly USA, LLC 6 $113.26
Incyte Corporation 2 $71.73
E.R. Squibb & Sons, L.L.C. 3 $66.48
Dermavant Sciences, INC. 3 $59.14
Ucb, INC. 3 $55.94

By nature of payment

Food and Beverage
$3,434
Education
$325

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,378
Patients
921
Total drug cost
$195,974
Drug Type Claims Patients Total cost
Fluocinonide Generic 181 132 $7,316
Clobetasol Propionate Generic 157 122 $7,945
Ciclopirox (Ciclopirox Olamine) Brand 142 105 $2,278
Fluorouracil Generic 131 124 $11,321
Ketoconazole Generic 131 70 $3,550
Metronidazole Generic 118 74 $6,590
Ammonium Lactate Generic 111 61 $2,242
Clindamycin Phosphate Generic 87 52 $4,938
Minoxidil Generic 76 20 $1,028
Triamcinolone Acetonide Generic 57 45 $678

Frequently asked questions

Auto-generated from federal data
What is Dr. Natalia Filipof's medical specialty?
Dr. Natalia Filipof practices Specialist in Grosse Pointe Woods, MI.
Where does Dr. Natalia Filipof practice?
Dr. Natalia Filipof practices at 20030 Mack Ave, Grosse Pointe Woods, MI 482362323. Office phone: 3138843380.
What is Dr. Natalia Filipof's NPI?
Dr. Natalia Filipof's National Provider Identifier (NPI) is 1245340975, issued by NPPES.
Does Dr. Natalia Filipof accept Medicare assignment?
Yes. Dr. Natalia Filipof accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Natalia Filipof commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.